Abstract
Febrile neutropenic patients have traditionally received hospital-based parenteral antibiotic therapy because of the risk of serious complications and associated mortality. Recently a low-risk subset among febrile neutropenic patients has been identified. Several alternatives to hospital-based therapy have been evaluated in such patients. These include early discharge to home antibiotic therapy after initial stabilization in the hospital, or treatment of the entire febrile episode with intravenous and/or oral antibiotics in an ambulatory setting. A multidisciplinary approach involving the physician and other health-care providers, the patients, and their families, ensures the success of this therapeutic modality. Careful patient selection, daily follow-up, close monitoring for the development of complications and/or adverse reactions, and informed consent along with detailed instructions to patients, minimize the risk of the development of serious complications. Outpatient antibiotic therapy for febrile episodes in low-risk neutropenic patients should now be considered an acceptable alternative to hospital-based therapy.
Similar content being viewed by others
References
Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infections in patients with acute leukemia. Ann Intern Med 64:328–339
Bodey GP, Fainstein V, Elting LS, Anaissie E, Rolston K, Khardori N (1990) B-lactam regimens for the febrile neutropenic patient. Cancer 65:9–16
Fainstein V, Rodriguez V, Turck M, Hermann G, Rosenbaum B, Bodey GP (1981) Patterns of oropharyngeal and fecal flora in patients with acute leukemia. J Infect Dis 144:10–18
Rolston K, Rubenstein EB, Frisbee-Hume S, Escalante C, Manzullo F, Wheeler A, Bodey GP (1993) Outpatient treatment of febrile episodes in low-risk neutropenic cancer patients (abstract 1505). Proceedings of the 29th Annual Meeting of the American Society of Clinical Oncology, vol 12. Saunders, Orlando, Fla
Rubenstein EB, Rolston K, Benjamin RS, Loewy J, Escalante C, Manzullo E (1993) Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 71:3640–3646
Rubin M, Hathorn JW, Pizzo PA (1988) Controversies in the management of febrile neutropenic cancer patients. Cancer Invest 6:167–184
Talcott JA, Finberg R, Mayer RJ, Goldman L (1988) The medical course of cancer patients with fever and neutropenia: clinical identification of a low-risk subgroup at presentation. Arch Intern Med 148:2561–2568
Talcott JA, Siegel RD, Finberg R, Goldman L (1992) Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 10:316–322
Talcott JA, Whalen A, Clark J, Rieker PP, Finberg R (1994) Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 12:107–114
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rubenstein, E.B., Rolston, K. Outpatient management of febrile episodes in neutropenic cancer patients. Support Care Cancer 2, 369–373 (1994). https://doi.org/10.1007/BF00344049
Issue Date:
DOI: https://doi.org/10.1007/BF00344049